Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
Jang Ho Cho, Joon-Ho Shim, Sang Eun Yoon, Hee-Jin Kim, Sun-Hee Kim, Young Hyeh Ko, Seung-Tae Lee, Kihyun Kim, Won Seog Kim, Seok Jin Kim
Korean J Intern Med. 2021;36(3):668-678. Published online 2020 Aug 14 DOI: https://doi.org/10.3904/kjim.2019.367
Citations to this article as recorded by 
Tumor-Associated Macrophage (TAM)-Related Cytokines, sCD163, CCL2, and CCL4, as Novel Biomarkers for Overall Survival and Time to Treatment in Waldenstrom’s Macroglobulinemia: Emphasis on Asymptomatic WM
Alexandros Gkiokas, Mavra Papadatou-Gigante, Annita Ioanna Gkioka, Aspasia Koudouna, Thomai M. Tryfou, Alexandros Alexandropoulos, Vassiliki Bartzi, Nikolitsa Kafasi, Marie-Christine Kyrtsonis
Cells.2025; 14(4): 275. CrossRef
Multicolor flow cytometry in the diagnosis of Waldenstrom macroglobulinemia
I. V. Galtseva, Yu. A. Tsoy, A. E. Grachev, N. M. Kapranov, K. A. Nikiforova, Yu. O. Davydova, A. A. Kulikov, E. E. Zvonkov, E. N. Parovichnikova
Oncohematology.2025; 20(1): 128. CrossRef
Antineoplastic drugs
Reactions Weekly.2021; 1870(1): 38. CrossRef